FDA Open To Industry Input On Separate IVD Least Burdensome Guidance

Industry recommendations on in vitro diagnostic sample data requirements will help FDA develop a separate least burdensome guidance on IVD products, CDRH Office of Device Evaluation Director Susan Alpert stated.